IPSEN (OTCMKTS:IPSEY) will announce its earnings results after the market closes on Thursday, February 15th.
Shares of IPSEN (IPSEY) opened at $32.80 on Wednesday. IPSEN has a twelve month low of $20.49 and a twelve month high of $36.13.
Separately, Zacks Investment Research cut shares of IPSEN from a “buy” rating to a “hold” rating in a report on Wednesday, December 27th.
COPYRIGHT VIOLATION WARNING: “IPSEN (IPSEY) to Release Quarterly Earnings on Thursday” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another site, it was illegally copied and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/02/14/ipsen-ipsey-to-release-quarterly-earnings-on-thursday.html.
Ipsen SA operates as a pharmaceutical company worldwide. It operates in two segments, Primary Care and Specialty Care. The company offers drugs in urology oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, a synthetic hormone made of triptorelin and decapeptide analog of gonadotrophin releasing hormone, for the treatment of advanced metastatic prostate cancer, uterine fibroids, precocious puberty, endometriosis, and female sterility; Hexvix, a photosensitizing agent, for detection and resection of non invasive bladder cancer; and Somatuline, which is an injectable treatment for acromegaly and neuroendocrine tumors.
Receive News & Ratings for IPSEN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IPSEN and related companies with MarketBeat.com's FREE daily email newsletter.